Five-year alendronate treatment outcome in older postmenopausal Japanese women with osteoporosis or osteopenia and clinical risk factors for fractures

Ítems similars

• Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures
  per: Iwamoto, Jun, et al.
  Publicat: (2010)
• Seven years’ experience with alendronate in postmenopausal Japanese women with osteoporosis
  per: Iwamoto, Jun, et al.
  Publicat: (2010)
• Hip fracture protection by alendronate treatment in postmenopausal women with osteoporosis: a review of the literature
  per: Iwamoto, Jun, et al.
  Publicat: (2008)
• Comparison of the Effects of Alendronate and Alfacalcidol on Hip Bone Mineral Density and Bone Turnover in Japanese Men Having Osteoporosis or Osteopenia with Clinical Risk Factors for Fractures
  per: Iwamoto, Jun, et al.
  Publicat: (2009)
• Effects of short-term combined treatment with alendronate and elcatonin on bone mineral density and bone turnover in postmenopausal women with osteoporosis
  per: Iwamoto, Jun, et al.
  Publicat: (2009)